Akari Therapeutics, Statistics
Total Valuation
AKTX has a market cap or net worth of $15.20 million. The enterprise value is $9.45 million.
Important Dates
The last earnings date was Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AKTX has 2.29 million shares outstanding. The number of shares has increased by 177.53% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 2.29M |
| Shares Change (YoY) | +177.53% |
| Shares Change (QoQ) | +85.53% |
| Owned by Insiders (%) | 26.30% |
| Owned by Institutions (%) | 33.73% |
| Float | 1.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.87 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.48, with zero debt.
| Current Ratio | 0.48 |
| Quick Ratio | 0.44 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.00 |
Financial Efficiency
Return on equity (ROE) is -146.32% and return on invested capital (ROIC) is -47.67%.
| Return on Equity (ROE) | -146.32% |
| Return on Assets (ROA) | -24.61% |
| Return on Invested Capital (ROIC) | -47.67% |
| Return on Capital Employed (ROCE) | -68.38% |
| Weighted Average Cost of Capital (WACC) | 12.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.90M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -774,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.90% in the last 52 weeks. The beta is 1.47, so AKTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | -64.90% |
| 50-Day Moving Average | 8.65 |
| 200-Day Moving Average | 8.86 |
| Relative Strength Index (RSI) | 43.42 |
| Average Volume (20 Days) | 37,618 |
Short Selling Information
The latest short interest is 17,903, so 1.41% of the outstanding shares have been sold short.
| Short Interest | 17,903 |
| Short Previous Month | 17,539 |
| Short % of Shares Out | 1.41% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.14M |
| Pretax Income | -30.18M |
| Net Income | -29.40M |
| EBITDA | n/a |
| EBIT | -16.14M |
| Earnings Per Share (EPS) | -$15.29 |
Full Income Statement Balance Sheet
The company has $5.74 million in cash and no debt, with a net cash position of $5.74 million or $2.51 per share.
| Cash & Cash Equivalents | 5.74M |
| Total Debt | n/a |
| Net Cash | 5.74M |
| Net Cash Per Share | $2.51 |
| Equity (Book Value) | 17.50M |
| Book Value Per Share | 7.66 |
| Working Capital | -6.71M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -12.86M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | -1.32M |
| Free Cash Flow | -12.86M |
| FCF Per Share | -$5.63 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AKTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -177.53% |
| Shareholder Yield | -177.53% |
| Earnings Yield | -229.93% |
| FCF Yield | -84.65% |
Analyst Forecast
The average price target for AKTX is $25.50, which is 283.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.50 |
| Price Target Difference | 283.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on March 31, 2026. It was a reverse split with a ratio of 1:40.
| Last Split Date | Mar 31, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |